Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 242

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

The melanocortin pathway and energy homeostasis: From discovery to obesity therapy

Open access
Yeo, Giles S.H., Chao, Daniela Herrera Moro, Siegert, Anna-Maria, Koerperich, Zoe M., Ericson, Mark D., Simonds, Stephanie E., Larson, Courtney M., Luquet, Serge, Clarke, Iain, Sharma, Shubh, Clément, Karine, Cowley, Michael A., Haskell-Luevano, Carrie, Van Der Ploeg, Lex, Adan, Roger A.H. · 2021 · Molecular Metabolism

Abstract

BACKGROUND: Over the past 20 years, insights from human and mouse genetics have illuminated the central role of the brain leptin-melanocortin pathway in controlling mammalian food intake, with genetic disruption resulting in extreme obesity, and more subtle polymorphic variations influencing the population distribution of body weight. At the end of 2020, the U.S. Food and Drug Administration (FDA) approved setmelanotide, a melanocortin 4 receptor agonist, for use in individuals with severe obesity due to either pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. SCOPE OF REVIEW: Herein, we chart the melanocortin pathway's history, explore its pharmacology, genetics, and physiology, and describe how a neuropeptidergic circuit became an important druggable obesity target. MAJOR CONCLUSIONS: Unravelling the genetics of the subset of severe obesity has revealed the importance of the melanocortin pathway in appetitive control; coupling this with studying the molecular pharmacology of compounds that bind melanocortin receptors has brought a new obesity drug to the market. This process provides a drug discovery template for complex disorders, which for setmelanotide took 25 years to transform from a single gene into an approved drug.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molmet.2021.101206

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 242

Metadata

Authors
Yeo, G. S. H., Chao, D. H. M., Siegert, A.-M., Koerperich, Z. M., Ericson, M. D., Simonds, S. E., Larson, C. M., Luquet, S., Clarke, I., Sharma, S., Clément, K., Cowley, M. A., Haskell-Luevano, C., Van Der Ploeg, L., & Adan, R. A. H.
Venue
Molecular Metabolism
Publisher
Elsevier BV
Published
2021-06
Volume
48
Pages
101206
ISSN
2212-8778 (ISSN-L)
OpenAlex
W3134781470
Cited by
242
References
43
FWCI
15.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The melanocortin pathway and energy homeostasis: From discovery to obesity therapy. https://app.cochat.ai/papers/10.1016/j.molmet.2021.101206
The paper
Yeo, G. S. H., Chao, D. H. M., Siegert, A.-M., Koerperich, Z. M., Ericson, M. D., Simonds, S. E., Larson, C. M., Luquet, S., Clarke, I., Sharma, S., Clément, K., Cowley, M. A., Haskell-Luevano, C., Van Der Ploeg, L., & Adan, R. A. H. (2021). The melanocortin pathway and energy homeostasis: From discovery to obesity therapy. Molecular Metabolism. https://doi.org/10.1016/j.molmet.2021.101206

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.